Sources
Primary references for every figure, claim, and statistic April Gate cites in its product, pitch materials, and public communications.
01 · The $35 Billion Loss
"The biopharma industry loses approximately $35 billion annually as a result of failures in temperature-controlled logistics."
02 · Vaccine Wastage
"More than 50% of vaccines may be wasted globally every year, in part due to temperature control, logistics, and shipment-related issues."
03 · Temperature Excursion Rates
"Approximately 12% of pharmaceutical shipments still experience temperature excursions, with up to 50% of vaccines compromised each year."
04 · Market Size & Growth
"The global pharma cold chain logistics market is projected at $27.7B by 2028 (5.26% CAGR); the broader cold chain market grows from $436B (2025) to $1.36T by 2034."
05 · Dispute Resolution & Claims Process
"Temperature excursion claims today are adjudicated through manual data-logger downloads and document review. Carriers publish multi-week SLAs for resolution; full insurance and legal disputes routinely extend further."
06 · Regulatory Framework
"April Gate's attestation outputs are designed to be compatible with the documentation and traceability requirements of EU GDP, US DSCSA, and IATA TCR."